Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tonsilotren in chronic tonsillitis
ISRCTN19016626Phase 3Completed
- Sponsor
- Deutsche Homöopathie-Union
- Start
- Jan 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of Tonsilotren in chronic tonsillitis (2 arms), sponsored by Deutsche Homöopathie-Union. Primary endpoint: Mean period of time between consecutive acute throat infections within one year. Started Jan 2013; status: completed.
02
Drugs
Tonsilotren
03
Conditions
chronic tonsillitis
Beyond the preview
Go deeper on ISRCTN19016626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN19016626.